IP Verse

Agents For Use In The Treatment Of Retinal Inflammation

Patent No. EP3096781 (titled "Agents For Use In The Treatment Of Retinal Inflammation") was filed by Centre National DE LA Recherche Scientifique Cnrs on Jan 22, 2015. The application was issued on Nov 2, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANAug 1, 2023D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3096781

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP15701194A
Filing Date
Jan 22, 2015
Status
Granted And Under Opposition
Sep 30, 2022
Publication Date
Nov 2, 2022
External Links
Slate, Register , Google Patents